FDA Approves First mRNA Flu Vaccine For Older Adults

Forbes News Agency

16 hours ago•Forbes

Stocks Medium Importance Neutral

FDA Approves First mRNA Flu Vaccine For Older Adults

"Flu remains a significant public health challenge, and mFLUSIVA provides an important new option for America's seniors. This approval also reflects the ongoing potential of our mRNA platform,” Moderna CEO Stéphane Bancel said.

Related Symbols 1

M MRNA MRNA

Source: Forbes

Visit Source

0 0 0

Comment

Comments

No comments yet

Be the first person to comment on this news item.

Category Stocks

Source Forbes

Published 16 hours ago

Likes 0

Comments 0

Shares 0

News ID #1,703

Status Published

This news may have been collected automatically from third-party sources. Please verify important information through the original source and other reliable sources before making any trading or investment decision. This content is provided for informational purposes only and does not constitute financial advice.

Keep comments relevant to the news topic and avoid offensive, promotional, spam, or misleading content.

FDA Approves First mRNA Flu Vaccine For Older Adults

Comments

User Menu